INS and metabolic disease: The role of long chain acylcarnitine is important in the development of metabolic disorders and our study underscores the need for further research aimed at understanding the specific mechanisms by which long chain acylcarnitines impair metabolic flexibility in both insulin resistant muscle fiber types.